Abstract

GIRALDO SANCHEZ, Javier Mauricio. SARS-CoV-2 patient with heparin-induced thrombocytopenia and white thrombi syndrome. Med. crít. (Col. Mex. Med. Crít.) [online]. 2023, vol.37, n.2, pp.141-145.  Epub May 13, 2024. ISSN 2448-8909.  https://doi.org/10.35366/110450.

Heparin-induced thrombocytopenia is an uncommon clinical entity, however the wide and massive use of anticoagulants in times of pandemic by COVID-19 reveals an evident reality and we can not escape. we present the case of a male patient in sixth decade of life with SARS-CoV-2 who after the administration of heparin in the clinical setting of thromboembolic lung disease development platelet consumption associated with the presence of antibodies anti platelet activating factor 4.

Keywords : thrombocytopenia; platelet- activating factor 4; dimer D; heparin; COVID-19.